Back to Journals » Therapeutics and Clinical Risk Management » Volume 12
Review
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Retargeting the management of hypercholesterolemia – focus on evolocumab
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
21,986 | Dovepress* | 20,527+ | 1,574 | 22,101 | |
PubMed Central* | 1,459 | 714 | 2,173 | ||
Totals | 21,986 | 2,288 | 24,274 | ||
*Since 6 September 2016 |
View citations on PubMed and Google Scholar